Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19

Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19

Patients with coronavirus disease-2019 (COVID-19) have an increased risk of thrombosis and acute respiratory distress syndrome (ARDS). Thrombosis is often attributed to increases in plasminogen activator inhibitor-1 (PAI-1) and a shut-down of fibrinolysis (blood clot dissolution). Decreased urokinas...

Full description

Bibliographic Details
Main Authors: Tetiana Yatsenko, Ricardo Rios, Tatiane Nogueira, Yousef Salama, Satoshi Takahashi, Yoko Tabe, Toshio Naito, Kazuhisa Takahashi, Koichi Hattori, Beate Heissig
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
COVID-19
plasminogen activator inhibitor-1
urokinase-type plasminogen activator
interleukin-6
fibrinolysis
thrombosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1299792/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1299792/full

Similar Items